Drugs / RIF
last change Sep 2015 re-read 3 minutes ago

RIF

Investigated by
GlaxoSmithKline · ViiV Healthcare

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02411435 Jul → Sep 2015 HIV infectious disease ViiV Healthcare Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RIF ClinicalTrials.gov intervention name — accepted as the source's own label NCT02411435 ↗